Aurora-A kinase nuclear expression in chronic lymphocytic leukemia

Modern Pathology

Volumn 21, Issue 12, 2008, Pages 1428-1435

  Inamdar, Kedar V ^a   O'Brien, Susan ^a   Sen, Subrata ^a   Keating, Michael ^a   Nguyen, Martin H ^a   Wang, Xuemei ^a   Fernandez, Michael ^a   Thomazy, Vilmos ^a   Medeiros, L Jeffrey ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aurora A; Chromatin; Chromosomes; CLL; p53

Indexed keywords

AURORA A KINASE; HISTONE H3; MESSENGER RNA;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA MUTATED GENE; BLOOD; BONE MARROW; BONE MARROW CELL; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN EXPRESSION; STAINING; TRISOMY 12; WESTERN BLOTTING;

ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL NUCLEUS; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56649094375     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.173     Document Type: Article

References (30)

1. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
2. Lampert IA, Wotherspoon A, Van Noorden S, et al. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. Hum Pathol 1999;30:648-654.
3. Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755-764.
4. Obermann EC, Went P, Tzankov A, et al. Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase. J Clin Pathol 2007;60:794-797.
5. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002;21:483-492.
6. Higuchi T, Uhlmann F. Cell cycle: passenger acrobatics. Nature 2003;426:780-781.
7. Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of poles. Nat Rev Cancer 2005;5:42-50.
8. Giet R, Prigent C. Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J Cell Sci 1999;112:3591-3601.
9. Terada Y, Tatsuka M, Suzuki F, et al. AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J 1998;17:667-676.
10. Yakushijin Y, Hamada M, Yasukawa M. The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma. Leuk Lymphoma 2004;45:1741-1746.
11. Bueso-Ramos CE, Ferrajoli A, Medeiros LJ, et al. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. Hematology (Amsterdam, Netherlands) 2004;9:279-286.
12. Schlette E, Bueso-Ramos C, Giles F, et al. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 2001;115:571-581.
13. Bulman AS, Heyderman E. Alkaline phosphatase for immunocytochemical labelling: problems with endogenous enzyme activity. J Clin Pathol 1981;34:1349-1351.
14. Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003;4:842-854.
15. Lee EC, Frolov A, Li R, et al. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006;66:4996-5002.
16. Crosio C, Fimia GM, Loury R, et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol 2002;22:874-885.
17. Sasayama T, Marumoto T, Kunitoku N, et al. Overexpression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1. Genes Cells 2005;10:627-638.
18. Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999;59(7 Suppl):1693s-1700s.
19. Bogner C, Schneller F, Hipp S, et al. Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways. Exp Hematol 2003;31:218-225.
20. Gritsko TM, Coppola D, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003;9:1420-1426.
21. Takahashi T, Futamura M, Yoshimi N, et al. Centrosomal kinases, HsAIRK1 and HsAIRK3, are overexpressed in primary colorectal cancers. Jpn J Cancer Res 2000;91:1007-1014.
22. Tanaka T, Kimura M, Matsunaga K, et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999;59:2041-2044.
23. Aguilar-Santelises M, Magnusson KP, Wiman KG, et al. Progressive B-cell chronic lymphocytic leukaemia frequently exhibits aberrant p53 expression. Int J Cancer 1994;58:474-479.
24. Miyoshi Y, Iwao K, Egawa C, et al. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 2001;92:370-373.
25. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002;94:1320-1329.
26. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-193.
27. Knuutila S, Elonen E, Teerenhovi L, et al. Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia. N Engl J Med 1986;314:865-869.
28. Que TH, Marco JG, Ellis J, et al. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood 1993;82:571-575.
29. Rowley JD, Testa JR. Chromosome abnormalities in malignant hematologic diseases. Adv Cancer Res 1982;36:103-148.
30. Kalachikov S, Migliazza A, Cayanis E, et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 1997;42:369-377.